Replies to post #364816 on Amarin Corp Plc (AMRN)

[Jasbg]

Raf, Thanks as always.

A mixed picture - but taken to account that Sales force reduced to half - brand Vasepa seems to hold on pretty well - after all :)

Happy New Year

[ralphey]

OMG that is hilarious ... AMRN is totally clueless ... maybe a magic sheroe will ride in on a unicorn and save them . I think I am going to harvest some losses before year end ...

[bidmark]

What happened to Reddy’s #s? Are they just included in Hikma’s?

[Number sleven]

Raf, As always thanks for the numbers. Hikma is still range bound.
DRL has almost equaled Hikma.
It will be interesting to see if Apotex puts up any numbers next week.
Sleven,

[Megc]

Thanks Raf, appreciate that you do this every week.

[Examiner77]

Thank you Raf

[rafunrafun]

Scripts for week ending December 24, 2021 - Christmas Eve

Drug Industry TRx: -6.7% w/w

Vascepa
TRx 74,313; -8.4% (-6,806) w/w; -8.0% y/y
NRx 33,715; -10.2% (-3,809) w/w; -10.6% y/y
Ref 40,598; -6.9% (-2,988) w/w; -5.7% y/y

Lovaza (Generic & Brand)
TRx 59,962; -7.5% (-4,882) w/w; +2.8% y/y
NRx 29,996; -8.9% (-2,935) w/w; -2.3% y/y
Ref 29,966; -6.1% (-1,948) w/w; +8.5% y/y

Generic Vascepa
TRx 24,143; -5.5% (-1,408) w/w; As % of total V: 24.5%
NRx 14,379; -3.3% (-50) w/w; As % of total V: 29.9%
Ref 9,764; -12.2% (-1,358) w/w; As % of total V: 19.4%

Generic Vascepa by Manufacturer
Hikma - TRx 12,034 (-1,943); Generic share 49.8%; Total V share 12.2%
Reddy - TRx 12,109 (+435); Generic share 50.2%; Total V share 12.3%

Vascepa + Generic Vascepa
TRx 98,456; -7.7% (-8,214) w/w; +15.6% y/y
NRx 48,094; -7.4% (-3,859) w/w; +20.1% y/y
Ref 50,362; -8.0% (-4,356) w/w; +11.6% y/y